Comerica Bank’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.13M Buy
24,325
+15,697
+182% +$657K ﹤0.01% 1442
2025
Q3
$302K Sell
8,628
-2,351
-21% -$81.7K ﹤0.01% 2148
2025
Q2
$325K Sell
10,979
-45
-0.4% -$1.28K ﹤0.01% 2099
2025
Q1
$329K Sell
11,024
-254
-2% -$7.76K ﹤0.01% 2069
2024
Q4
$323K Sell
11,278
-13,571
-55% -$449K ﹤0.01% 2093
2024
Q3
$960K Buy
24,849
+839
+3% +$29.9K ﹤0.01% 1566
2024
Q2
$773K Sell
24,010
-1,072
-4% -$37.2K ﹤0.01% 1628
2024
Q1
$974K Buy
25,082
+9,647
+63% +$338K ﹤0.01% 1549
2023
Q4
$475K Sell
15,435
-666
-4% -$16.7K ﹤0.01% 1877
2023
Q3
$360K Buy
+16,101
New +$367K ﹤0.01% 1941
2022
Q4
$567K Sell
19,965
-6,229
-24% -$126K ﹤0.01% 1720
2022
Q3
$461K Sell
26,194
-3,285
-11% -$57.9K ﹤0.01% 1805
2022
Q2
$498K Hold
29,479
﹤0.01% 1833
2022
Q1
$532K Sell
29,479
-275
-0.9% -$5.2K ﹤0.01% 1846
2021
Q4
$539K Sell
29,754
-2,579
-8% -$50.3K ﹤0.01% 1841
2021
Q3
$681K Sell
32,333
-684
-2% -$14.8K ﹤0.01% 1836
2021
Q2
$657K Sell
33,017
-2,354
-7% -$54.4K ﹤0.01% 1916
2021
Q1
$823K Buy
+35,371
New +$840K ﹤0.01% 1847

Other funds holding COLL

Comerica Bank's COLL Position: Q4 2025 in Review

Comerica Bank increased its Collegium Pharmaceutical (COLL) stake by 182% in Q4 2025, buying an estimated $657K and bringing the position to 24,325 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

Comerica Bank first reported a position in COLL in Q1 2021 and has held it in 18 quarters since. 278 funds tracked by Wall St. Rank hold COLL as of Q4 2025.

  • Comerica Bank held 24,325 shares of Collegium Pharmaceutical worth $1.13M as of Q4 2025.
  • Comerica Bank bought 15,697 Collegium Pharmaceutical shares in Q4 2025, an estimated $657K.
  • Collegium Pharmaceutical made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1442 holding.
  • Comerica Bank first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 18 quarters since.
  • 278 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.